vendredi 26 octobre 2018

Why Private Equity is Furious Over a Paper in a Dermatology Journal

The sudden, unexplained removal of a research paper on private equity firms buying dermatology practices has raised questions about corporate influence.

from NYT > Health https://ift.tt/2PnvHFe
via health&fitness

Aucun commentaire:

Enregistrer un commentaire